School of Medicine
Showing 8,601-8,650 of 13,048 Results
-
David J. Park, MD, PhD, FCNS
Clinical Assistant Professor, Neurosurgery
Current Research and Scholarly InterestsThe goal of our Laboratory is to improve patients’ care and outcomes by analyzing clinical data from thousands of patients treated at our institution. Our current primary areas of interest are benign tumors, brain and spine metastases, and neurogenetic disorders.
Our lab is led by Dr. Steven D. Chang and Dr. David J. Park and proudly hosts talented young clinical scientists from around the world.
Link: https://med.stanford.edu/neurosurgery/research/NeuroOncLab.html -
Eunkyung Angela Park, MD, PhD
Clinical Associate Professor, Radiology - Rad/Nuclear Medicine
BioDr. Eunkyung Angela Park is a Clinical Associate Professor (affiliated) at the Department of Radiology at Stanford and Nuclear Medicine Staff Physician at Palo Alto VA Medical Center. She takes care of patients having cancer, various diseases in the brain, heart and other organs through molecular imaging and targeted radiopharmaceutical therapies. Dr. Park graduated from Seoul National University College of Medicine and completed clinical and research training at Seoul National University Hospital, Yale University PET Center, University of Iowa Hospitals and Clinics. She served as Associate Section Chief in Nuclear Medicine at University of Utah before joining Stanford. Her main professional interests include global promotion of nuclear medicine, clinical/translational research in nuclear neurology, and operational system innovation. Dr. Park is particularly interested in early and accurate differential diagnoses of mixed neurodegenerative disorders by using brain PET imaging with various radiopharmaceuticals targeting glucose metabolism, amyloid, tau, neuroreceptors and transporters. She enjoys traveling, practicing yoga, playing tennis and anything about music.
-
Jon Park, MD, FRCSC
Saunders Family Professor
Current Research and Scholarly InterestsNon-fusion dynamic spinal stabilization, artificial disc technologies, and regenerative spinal technologies.
-
Jun Hyung Park
Research and Development Science and Engineer 1, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordI joined in Cyclotron and radiochemstry facility in 2014. I focus on routine radiopharmaceutical production, including 18F tracers (18F-Flumazenil, 18F-FTC-146, 18F-FLT, 18F Arag, 18F-FSPG etc.); 11C tracers (11C UCB-J, 11C-raclopride, 11C-PIB, 11C-methionine, 11C DPA-713 etc.); 15O-H2O and 68Ga-DOTATATE radiochemistry for clinical use and supporting various of pre-clinical studies.
-
Junyoung Park
Postdoctoral Scholar, Neurology and Neurological Sciences
BioDr. Jun Young graduated from the Department of Biostatistics at the School of Public Health, Seoul National University, Korea. His major field of study is biostatistics, with a specific focus on the application of machine learning and statistical analysis to medical imaging and genetic data. During his doctoral studies, he concentrated on two primary research areas. Firstly, he dedicated himself to the development of deep learning models for medical images, primarily centered on T1-MRI and cognitive function test images related to Alzheimer's Disease. Secondly, he engaged in extensive genome-wide association analyses of medical images associated with Alzheimer's Disease, using statistical algorithms to uncover novel insights into the genetic factors contributing to this complex condition. Currently, as a postdoctoral fellow at the Greicius Lab at Stanford, he aims to develop statistical methods to discover novel structural variants and model polygenetic risk scores using long-read sequencing data.
-
KT Park MD MS
Adjunct Professor, Medicine - Med/Gastroenterology and Hepatology
BioPrior to joining Genentech in 2018, Dr. Park was Associate Professor at Stanford University School of Medicine, Co-Director of the IBD Center at Stanford Children’s Health, and an expert in Crohn’s disease and ulcerative colitis. Currently, he is the Global Head of Gastroenterology, Hepatology & Metabolism in Product Development at Genentech and Roche. Trained as a health economist, during his tenure in academia, Dr Park held research grants and funding support focused on the cost-effectiveness of biologic treatment strategies and novel non-invasive biomarkers for children and adults with IBD. He led national research registries at the Crohn’s & Colitis Foundation and scientific/clinical committees in numerous GI societies and physicians’ organizations. He received his BA in chemistry/biochemistry at Duke University, MD at University of Tennessee, and MSc in Health Economics/Policy at Stanford where he completed his clinical and postdoctoral trainings. He is Adjunct Professor of Medicine in the Division of Gastroenterology & Hepatology at Stanford University. At Genentech Roche, Dr. Park directs a team of clinical scientists and medical directors overseeing clinical phase drug development in gastroenterology, hepatology, and metabolism.
-
Lesley Park
Senior Research Scientist, Epidemiology and Population Health
BioStanford Advancing Health Equity and Diversity (AHEaD)
ahead.stanford.edu
Founding Co-Director (2020-present)
Veterans Aging Cohort Study (VACS)
Executive Director (2022-present)
Cancer Core Co-Director (2016-present)
International Workshop on HIV and Hepatitis Observational Databases (IWHOD)
iwhod.org
Chair, Scientific Secretariat (2024-present)
Dr. Lesley Park is a co-founding director of the Stanford AHEaD summer research program for college students from underrepresented and historically excluded groups in the health sciences. She is also the Executive Director of the VACS consortium, an international collaboration of methodologists, clinicians, and trainees who utilize the rich and valuable data from the Veterans Health Administration to do impactful research. VACS has been at the forefront of research to understand aging with HIV to improve patient care, particularly with respect to alcohol and other substance use, physiologic frailty, and polypharmacy. In recent years, the VACS mission has expanded to encompass other foci, including genomic research and most recently COVID-19.
Within the VACS, Dr. Park oversees cancer and COVID-19 outcomes research in persons with HIV/AIDS (PWH). Her research experience has focused on the intersection of cancer and HIV, examining epidemiologic methods for cancer research, cancer incidence trends, and cancer (particularly hepatocellular carcinoma) prevention in PWH. Dr. Park is an experienced epidemiologist, skilled in "big data" observational research, survival analysis, and SAS programming. She teaches courses in computing, data management, and epidemiologic analysis methods. Her prior experience includes research at the Yale School of Medicine and at the Center for Biostatistics in AIDS Research (CBAR) at the Harvard School of Public Health.
The International Workshop on HIV and Hepatitis Observational Databases (IWHOD) is an established scientific forum for the appropriate application of real-world data to emerging issues in infectious disease. Dr. Park leads the IWHOD scientific committee of internationally reknowned experts in infectious disease and is responsible for administrative and scientific coordination of IWHOD.
Previously, Dr. Park was one of the leaders of the Stanford Center for Population Health Sciences (PHS). PHS aims to improve the health of populations by bringing together diverse disciplines and data to understand and address social, environmental, behavioral, and biological factors. She oversaw all of the educational and training initiatives at PHS and was one of the founding directors of the PHS Data Center and PHS Postdoctoral Fellowship program. -
Namu Park
Postdoctoral Scholar, Biomedical Informatics
BioDr. Park is a Postdoctoral Scholar at the Division of Computational Medicine at Stanford University, where he is co-advised by Dr. Tina Hernandez-Boussard and Dr. Yair Bannet. He received his PhD in Biomedical and Health Informatics from the University of Washington.
His research focuses on clinical natural language processing and large language models for healthcare. He develops clinically grounded information extraction methods and evaluation frameworks that reflect real-world clinical workflows. His work examines how large language models can be aligned with clinical reasoning and rigorously evaluated for safe and effective deployment in health systems.
Through interdisciplinary collaboration, Dr. Park aims to bridge advances in foundation models with measurable clinical impact, emphasizing reliability, transparency, and scalability in AI-driven healthcare applications. -
Walter Park
Professor of Medicine (Gastroenterology and Hepatology)
Current Research and Scholarly InterestsDr. Park's research interests are in the diagnosis and management of pancreatic cysts, acute and chronic pancreatitis. His approach incorporates methods in health services research including the use of observational datasets, cost-effectiveness studies, and the development of clinical cohorts.
-
Karen J. Parker, PhD
Truong-Tan Broadcom Endowed Professor and Professor, by courtesy, of Comparative Medicine
Current Research and Scholarly InterestsThe Parker Lab conducts research on the biology of social functioning in monkeys, typically developing humans, and patients with social difficulties.
-
Robertson Parkman
Other Teaching Staff-Hourly, Pediatrics - Stem Cell Transplantation
BioMy principal research interests have been the assessment of the immunological consequences of hematopoietic stem cell transplantation including both acute and chronic graft versus host disease and immune reconstitution and the use of hematopoietic stem cell transplantation to treat genetic diseases. My laboratory was the first to suggest that chronic graft versus host disease was an autoimmune disease directed at histocompatibility antigens shared by donors and recipients. The observation leaded to the assessment of the role of thymic dysfunction in the pathogenesis of chronic graft versus host disease. As a pediatric immunologist I have investigated the role of hematopoietic stem cell transplantation initially in the treatment of primary immune deficiency diseases and later the treatment of metabolic diseases, which lead to my involvement in the early gene transfer clinical trials.
-
Ugur Parlatan
Basic Life Research Scientist, Rad/Canary Center at Stanford for Cancer Early Detection
BioDr. Ugur Parlatan is a Basic Life Research Scientist at the Canary Center at Stanford for Cancer Early Detection. Trained as a physicist, he leads photonics laboratory activities and develops optical spectroscopy and imaging approaches for molecular fingerprinting and characterization of extracellular vesicles (EVs). His work includes designing and optimizing measurement workflows, analyzing EV signatures from biomedical samples, and supporting disease-focused studies across cancer and metabolic conditions (including lung cancer, glioblastoma, pancreatic cancer, diabetes, and hepatotoxicity). He also mentors trainees (including NIH CREST program interns) and contributes to manuscripts and grant applications.
-
Jane Parnes
Professor of Medicine, Emerita
Current Research and Scholarly InterestsThe lab is studying the mechanisms controlling B cell responsiveness and the balance between tolerance and autoimmunity. B cells deficient in CD72 are hyperresponsive to stimulation through the B cell receptor. We are examining the alterations in B cell signaling in these B cells and the mechanisms by which CD72 deficiency partially abrogates anergic tolerance. We hope to learn how deficiency in CD72 leads to spontaneous autoimmunity and increased susceptibility to induced autoimmune disease.
-
Shyon Parsa
Affiliate, Department Funds
Resident in MedicineBioShyon earned his B.S. in Biomedical Engineering from the Cockrell School of Engineering at the University of Texas - Austin, graduating with Honors. He completed coursework in Thermodynamics and Transport Phenomena in Living Systems at the Department of Applied Mathematics and Theoretical Physics at Cambridge University under Clare Hall fellow Dr. Kenneth Diller. After graduation, Shyon enrolled in medical school at UT Southwestern, and graduated with an M.D with Distinction in Research and as a member of the Alpha Omega Alpha (AOA) honor society.
He started his internal medicine residency at Stanford University Hospital in 2023. In 2024, he was awarded a Stanford Cardiovascular Institute Seed Grant for his project "An Artificial Intelligence Approach Utilizing Radiomic-Derived Calcium Features on Calcium Scoring CT (CAC-CT) in Cardiovascular Risk Stratification" (Co-PI). In 2025, he was selected for a Young Investigator Award from the National Lipid Association and named as an American Heart Association Early Career Investigator Award finalist. His works have been highlighted in the New England Journal of Medicine AI, Journal of the Academic College of Cardiology, and Journal of the American Heart Association.
His interests include the development of AI-enabled ECG models, the implementation and evaluation of AI tools in clinical workflows, and policy surrounding the responsible use of AI in health systems. He is pursuing a career in cardiology with a focus on electrophysiology, medical device development, and policy. -
Susan Julia Parson
Clinical Assistant Professor (Affiliated), Pathology Clinical
Staff, Pathology Operations supported expensesBioAssistant Medical Examiner-Coroner / Forensic Pathologist
Santa Clara County Office of the Medical Examiner-Coroner
850 Thornton Way San Jose, CA 95128
(408) 793-1900
https://mec.santaclaracounty.gov/home -
Julie Parsonnet
George DeForest Barnett Professor of Medicine, Emerita
Current Research and Scholarly InterestsI am an infectious diseases epidemiologist who has done large field studies in both the US and developing countries. We research the long-term consequences of chronic interactions between the human host and the microbial world. My lab has done fundamental work establishing the role of H. pylori in causing disease and understanding its epidemiology. Currently, our research dissects how and when children first encounter microbes and the long term effects of these exposures on health.
-
Sonia Partap
Clinical Professor, Pediatric Neurology
Clinical Professor (By courtesy), Neurosurgery
Clinical Professor (By courtesy), PediatricsCurrent Research and Scholarly InterestsMy research interests involve the epidemiology, treatment and diagnosis of pediatric and young adult brain tumors. I am also interested in long-term neurologic effects and designing clinical trials to treat brain and spinal cord tumors.
